Trends in the Use of IV Iron and ESAs Under the Prospective Payment System: ESRD Commercial and Medicare Populations

Project Details

StatusFinished
Effective start/end date1/07/15 → 30/06/16

Funding

  • Keryx Biopharmaceuticals, Inc.: $76,500.00

Keywords

  • Chronic Kidney Disease, Health Services Research